Boston, MA -- (SBWIRE) -- 01/22/2014 -- BioMarker Strategies, LLC (BioMarker Strategies) is a tissue-based cancer diagnostics company. The company's product SnapPath, a novel automated tumor biopsy processing and testing system, is used to test and analyze a patient's live solid tumor sample at the point of biopsy. Its SnapPath platform enables the development of PathMap profiles which help guide targeted drug treatment selection, including drug combinations. BioMarker Strategies SnapPath units are being utilized in human clinical and preclinical studies for advanced melanoma and other solid tumors. The company also develops a series of functional, pathway-based, and ex vivo biomarker tests to guide an oncologist's. BioMarker Strategies is headquartered in Rockville, Maryland, the US.

This report is a source for data, analysis and actionable intelligence on the BioMarker Strategies, LLC portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

View Full Report Details and Table of Contents

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.<\li> - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.<\li> - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.<\li> - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.<\li> - Data on relevant clinical trials and product patent details, wherever applicable.<\li> - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get This Report

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.<\li> -

Companies Mentioned in this Report: BioMarker Strategies, LLC

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Proplex Technologies, Llc - Product Pipeline Analysis, 2013 Update
- AnalizaDx, LLC - Product Pipeline Analysis, 2013 Update
- GeneNews Limited (GEN) - Product Pipeline Analysis, 2013 Update
- Innovia LLC - Product Pipeline Analysis, 2013 Update
- US Biomarkers, Inc. - Product Pipeline Analysis, 2013 Update
- Ceres Nanosciences, Inc. - Product Pipeline Analysis, 2013 Update
- Biocrates Life Sciences AG - Product Pipeline Analysis, 2013 Update
- bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2013 Update
- Genisphere Inc. - Product Pipeline Analysis, 2013 Update
- Advanced Bionics, LLC - Product Pipeline Analysis, 2013 Update